Clearwater to buy software maker Enfusion for $1.5 billion

Clearwater Analytics to buy Enfusion for $11.25 a share
Clearwater Analytics (NYSE:CWAN) has agreed to acquire Enfusion (NYSE:ENFN) for $11.25 a share, delivered in an approximately equal mix of cash and stock. Clearwater (NYSE:CWAN) is expected to pay a total of approximately $760M in cash and issue between approximately 23M and 28M new shares to Enfusion (NYSE:ENFN) shareholders.
Clearwater Analytics to buy software maker Enfusion for $1.5 billion to drive global expansion
Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge fund industry.
Clearwater acquires Enfusion in $1.5B financial software deal
Clearwater Analytics Holdings Inc. today announced plans to acquire Enfusion Inc., a fellow provider of financial software, for $1.5 billion in cash and stock.
Clearwater Analytics to Acquire Enfusion for $1.5 Billion Expanding its Investment Management Platform with Front-to-Back Capabilities
Clearwater Analytics (NYSE: CWAN) ("Clearwater") and Enfusion, Inc. (NYSE: ENFN) ("Enfusion") today announced their entry into a definitive merger agreement for Clearwater to acquire Enfusion, a leader in software-as-a-service (SaaS) solutions for the investment management and hedge fund industry.
Clearwater to acquire Enfusion to expand its Investment Management Platform
IBS Intelligence (IBSi) is the world’s only pure-play Financial Technology focused research, advisory, and fintech news analysis firm, with a 30-year track record and clients globally. We take pride in covering 400+ technology vendors globally – the largest by any analyst firm in this space.
Clearwater Analytics Buys Enfusion in $1.5 Bln Deal
Clearwater Analytics struck a deal to buy software company Enfusion in a deal worth $1.5 billion, bolstering its efforts to build a cloud platform for the investment-management industry.
Clearwater Analytics to acquire Enfusion for $11.25 per share in cash, stock
EST Clearwater Analytics (CWAN) to acquire Enfusion (ENFN) for $11.25 per share in cash, stockStay Ahead of the Market:Discover
Clearwater to buy Enfusion for $1.5bn
Clearwater Analytics is building out its investment management platform through the $1.5 billion acquisition of SaaS outfit Enfusion.
Clearwater to buy software maker Enfusion for $1.5 billion in expansion push
Clearwater Analytics has agreed to acquire Enfusion in a $1.5 billion cash-and-stock deal as the financial software maker looks to bolster its international presence and enter the hedge fund industry.
Clearwater To Acquire Enfusion - Quick Facts
Clearwater Analytics (CWAN) and Enfusion (ENFN) announced a definitive merger agreement for Clearwater to acquire Enfusion. Enfusion
Clearwater Analytics to acquire Enfusion in $1.5 billion deal
Clearwater Analytics has agreed to acquire investment management platform Enfusion in a $1.5 billion cash-and-stock deal, the companies said on Monday. Enfusion shareholders will receive $5.85 in cash and $5.
Clearwater agrees to buy investment management platform Enfusion for $1.5B
Clearwater Analytics said it has entered into a definitive agreement to acquire investment management platform Enfusion for ...
Clearwater Analytics Holdings (CWAN) Receives a Buy from William Blair
In a report released today, Dylan Becker from William Blair maintained a Buy rating on Clearwater Analytics Holdings (CWAN – Research Report).
Business Wire8h
ENFUSION INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of En…
Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are ...
Here are the Reasons to Invest in Clearwater Analytics Holdings (CWAN)
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” fourth ...